Immunoglobulins in epilepsy.
J A
JA
Aarli
D000927:Anticonvulsants / Q000009:adverse effects; D001323:Autoantibodies / Q000276:immunology; D001424:Bacterial Infections / Q000503:physiopathology; D004247:DNA / Q000096:biosynthesis; D004406:Dysgammaglobulinemia / Q000139:chemically induced; D004827:Epilepsy / Q000097:blood* / Q000188:drug therapy / Q000276:immunology / Q000473:pathology; D005492:Folic Acid / Q000378:metabolism; D006801:Humans; D017098:IgA Deficiency; D007107:Immune System / Q000187:drug effects / Q000473:pathology; D007113:Immunity, Innate; D007070:Immunoglobulin A / Q000378:metabolism; D007071:Immunoglobulin A, Secretory / Q000378:metabolism; D007136:Immunoglobulins / Q000378:metabolism*; D010672:Phenytoin / Q000009:adverse effects / Q000627:therapeutic use; D013601:T-Lymphocytes / Q000145:classification; D000509:alpha-Fetoproteins / Q000378:metabolism
D000927:Anticonvulsants; D001323:Autoantibodies; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007136:Immunoglobulins; D000509:alpha-Fetoproteins; D010672:Phenytoin; D004247:DNA; D005492:Folic Acid